ERBB2 and metastatic malignant neoplasm in the lymph nodes: This study identified that younger age, married status, earlier T stage, no lymph node metastasis, poor differentiation, ER−/PR−, HER2+, and receiving chemotherapy were more likely to achieve pCR after NAT.